Human Vaccines & Immunotherapeutics
Impact Factor Trend (2018–2026)
Clarivate IF trend for Human Vaccines & Immunotherapeutics
SCImago Journal Rank citation prestige weighting
113 papers with at least that number of citations each
Aims & Scope
(formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
IMMUNOLOGY
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
IMMUNOLOGY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisHuman Vaccines & Immunotherapeutics (acronym: hv, abbr: HUM VACC IMMUNOTHER, ISSN: 2164-5515) is a peer-reviewed international scholarly journal in the field of BIOTECHNOLOGY & APPLIED MICROBIOLOGY, published by Landes Bioscience in United States since 2005. The periodical holds a Journal Impact Factor (JIF) of 4.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.094 (Q1), an H-index of 113.
The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 547 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,333 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics